Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website https://gr.elmerpub.com

Original Article

Volume 000, Number 000, March 2025, pages 000-000


Incidence of Inflammatory Bowel Disease in Children

Figures

Figure 1.
Figure 1. Flow chart of study design.
Figure 2.
Figure 2. Number of new cases of UC, CD, and IBD-U per year. CD: Crohn’s disease; IBD-U: unclassified inflammatory bowel disease; UC: ulcerative colitis.
Figure 3.
Figure 3. Number of children with newly diagnosed IBD, UC, CD, and IBD-U (per 100,000 children) in the Kujawsko-Pomorskie voivodeship. CD: Crohn’s disease; IBD-U: unclassified inflammatory bowel disease; UC: ulcerative colitis.
Figure 4.
Figure 4. Trend in IBD incidence in children by age subgroup. IBD: inflammatory bowel disease.

Tables

Table 1. Characteristics of the Study Group at the Time of Data Collection
 
CharacteristicIBD (n = 118) (100%)IBD (n = 118) (100%)
UC (n = 57) (48.3%)CD (n = 48) (40.68%)IBD-U (n = 13) (11.02%)P
aRural: less than 2000 inhabitants. bUrban: more than 2000 inhabitants. CD: Crohn’s disease; IBD: inflammatory bowel disease; IBD-U: unclassified inflammatory bowel disease; SD: standard deviation; UC: ulcerative colitis.
Age at the time of diagnosis in years0.066
  Mean ± SD11.67 ± 4.1512.47 ± 3.5211.38 ± 4.59.23 ± 4.59
  Min - Max2 - 184 - 172 - 183 - 17
Sex, n (%)0.892
  Girls52 (44%)25 (44%)22 (46%)5 (38%)
  Boys66 (56%)32 (56%)26 (54%)8 (62%)
Place of residence, n (%)0.379
  Rurala36 (31%)21 (37%)12 (25%)3 (23%)
  Urbanb82 (69%)36 (63%)36 (75%)10 (77%)
First-degree relatives of IBD, n (%)18 (15%)7 (12%)10 (21%)1 (8%)0.174
  Mother9 (8%)2 (4%)7 (15%)0 (0%)
  Father5 (4%)2 (4%)2 (4%)1 (8%)
  Siblings4 (3%)3 (5%)1 (2%)0 (0%)

 

Table 2. Children With IBD With Regard to Age at the Time of Diagnosis, Onset of the First Symptoms, Sex, the Severity of Course, and Place of Residence in the Period 2011 - 2022
 
Characteristic2011 – 2022, n = 118 (100%)2011 – 2016, n = 48 (100%)2017 – 2022, n = 70 (100%)P
CD: Crohn’s disease; IBD: inflammatory bowel disease; UC: ulcerative colitis.
Mean age of onset of the first symptoms in years
  IBD10.48 ± 4.579.33 ± 4.9511.27 ± 4.410.023
  UC11.40 ± 4.2510.26 ± 5.4211.97 ± 3.470.363
  CD10.06 ± 4.749.81 ± 4.6410.26 ± 4.90.594
Mean age of diagnosis in years
  IBD11.67 ± 4.1510.75 ± 4.5112.3 ± 3.790.046
  UC12.47 ± 3.5212.11 ± 3.9412.66 ± 3.320.734
  CD11.38 ± 4.510.71 ± 4.5711.89 ± 4.470.296
Age at the time of diagnosis
  IBD0.013
    < 6 years of age15 (12.71%)11 (22.92%)4 (5.71%)
    ≥ 6 years of age103 (87.29%)37 (77.08%)66 (94.29%)
  UC0.033
    < 6 years of age3 (2.54%)3 (6.25%)0 (0.00%)
    ≥ 6 years of age54 (45.76%)16 (33.33%)38 (54.29%)
  CD0.715
    < 6 years of age8 (6.78%)4 (8.33%)4 (5.71%)
    ≥ 6 years of age40 (33.90%)17 (35.42%)23 (32.86%)
Sex
  IBD0.896
    Girls52 (44.07%)21 (43.75%)31 (44.29%)
    Boys66 (55.93%)27 (56.25%)39 (55.71%)
  UC0.925
    Girls25 (21.19%)8 (16.67%)17 (24.29%)
    Boys32 (27.12%)11 (22.92%)21 (30.00%)
  CD0.942
    Girls22 (18.64%)10 (20.83%)12 (17.14%)
    Boys26 (22.03%)11 (22.92%)15 (21.43%)
Severity of course/number of patients on biological therapy0.024
  IBD36 (30.5%)17 (35.42%)19 (27.14%)
  UC15 (12.71%)4 (8.33%)11 (15.71%)
  CD17 (14.41%)9 (18.75%)8 (11.43%)
Severity of course/number of patients without biological therapy0.851
  IBD82 (69.49%)31 (64.58%)51 (72.86%)
  UC41 (34.75%)15 (31.25%)27 (38.57%)
  CD31 (26.27%)12 (25%)19 (27.14%)
Place of residence
  IBD0.641
    Urban82 (69.49%)35 (72.92%)47 (67.14%)
    Rural36 (30.51%)13 (27.08%)23 (32.86%)
  UC0.771
    Urban36 (30.51%)11 (22.92%)25 (35.71%)
    Rural21 (17.80%)8 (16.67%)13 (18.57%)
  CD0.867
    Urban36 (30.51%)16 (33.33%)20 (28.57%)
    Rural12 (10.17%)5 (10.42%)7 (10.00%)

 

Table 3. Number of Patients According to the Season of the First Symptoms
 
Seasons2011 - 2022, n = 118 (100%)2011 - 2016, n = 48 (100%)2017 - 2022, n = 70 (100%)P
CD: Crohn’s disease; IBD: inflammatory bowel disease; UC: ulcerative colitis.
Spring, n (%)0.276
  IBD34 (28.8%)16 (33.33%)18 (24.71%)
  UC18 (15.25%)6 (12.5%)12 (17.14%)
  CD10 (8.47%)6 (12.5%)4 (5.71%)
Summer, n (%)0.875
  IBD31 (26.27%)14 (29.17%)17 (24.29%)
  UC15 (12.71%)6 (12.5%)9 (12.86%)
  CD13 (11.01%)7 (14.58%)6 (8.57%)
Autumn, n (%)0.479
  IBD33 (27.97%)10 (20.83%)23 (32.86%)
  UC16 (13.56%)5 (10.42%)11 (15.71%)
  CD16 (13.56%)4 (8.33%)12 (17.14%)
Winter, n (%)0.580
  IBD20 (16.95%)8 (16.67%)12 (17.14%)
  UC8 (6.78%)2 (41.17%)6 (8.57%)
  CD9 (7.63%)4 (8.33%)5 (7.14%)